Carregant...
280 Use of Omalizumab in Chronic Moderate to Severe Persistent Asthma-an Indian Experience
BACKGROUND: The worldwide prevalence of asthma is high and increasing. In India prevalence of asthma is variable from 4% to 20%. Despite ICS plus LABA therapy 72% of asthma patients were uncontrolled or not well controlled in INSPIRE study. Immunoglobulin-E plays a central role in inflammatory casca...
Guardat en:
| Autors principals: | , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
World Allergy Organization Journal
2012
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3512853/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/01.WOX.0000412037.69878.04 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|